Report Content
Chapter 1 Methodology & Scope
1.1 Research Methodology
1.1.1 Initial data exploration
1.1.2 Statistical modeling and forecast
1.1.3 Industry insights and validation
1.1.4 Research scope & assumptions
1.2 List of Data Sources
Chapter 2 Executive Summary
2.1 Egg phosphatidylcholine industry 3600 synopsis, 2013 - 2024
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Application trends
Chapter 3 Egg Phosphatidylcholine Industry Insights
3.1 Industry segmentation
3.2 Industry size, forecast and growth expectation, 2013 - 2024
3.3 Industry ecosystem analysis
3.3.1 Vendor matrix
3.4 Industry dynamics
3.4.1 Growth drivers
3.4.1.1 Increase in ageing population
3.4.1.2 Cosmetic industry expansion
3.4.1.3 Choline as a nutrient source
3.4.2 Industry pitfalls & challenges
3.4.2.1 Health concerns related with phosphatidylcholine
3.4.2.2 Substitute threat
3.5 Key growth opportunities
3.5.1 Key growth opportunities – Egg phosphatidylcholine
3.6 Porter’s analysis
3.7 Competitive landscape, 2015
3.8 PESTEL analysis
Chapter 4 Egg Phosphatidylcholine Application Insights
4.1 Global egg phosphatidylcholine market volume by product, 2015 & 2024
4.2 Pharmaceutical
4.2.1 Market estimates and forecast, 2013-2024
4.2.2 Market estimates and forecast, by region, 2013-2024
4.3 Cosmetics
4.3.1 Market estimates and forecast, 2013-2024
4.3.2 Market estimates and forecast, by region, 2013-2024
4.4 Dietetics
4.4.1 Market estimates and forecast, 2013-2024
4.4.2 Market estimates and forecast, by region, 2013-2024
Chapter 5 Egg Phosphatidylcholine Regional Insights
5.1 Egg phosphatidylcholine market volume by region, 2015 & 2024
5.2 North America
5.2.1 Market estimates and forecast, 2013-2024
5.2.2 Market estimates and forecast, by application, 2013-2024
5.2.3 U.S.
5.2.3.1. Market estimates and forecast, 2013 – 2024
5.2.3.2 Market estimates and forecast, by application, 2013 – 2024
5.2.4 Canada
5.2.4.1. Market estimates and forecast, 2013 – 2024
5.2.4.2 Market estimates and forecast, by application, 2013 – 2024
5.3 Europe
5.3.1 Market estimates and forecast, 2013-2024
5.3.2 Market estimates and forecast, by application, 2013-2024
5.3.3 UK
5.3.3.1. Market estimates and forecast, 2013 – 2024
5.3.3.2. Market estimates and forecast, byapplication, 2013 – 2024
5.3.4 Germany
5.3.4.1. Market estimates and forecast, 2013 – 2024
5.3.4.2 Market estimates and forecast, byapplication, 2013 – 2024
5.3.5 France
5.3.5.1. Market estimates and forecast, 2013 – 2024
5.3.5.2. Market estimates and forecast, by application, 2013 – 2024
5.3.6 Italy
5.3.6.1. Market estimates and forecast, 2013 – 2024
5.3.6.2. Market estimates and forecast, by application, 2013 – 2024
5.3.7 Russia
5.3.7.1. Market estimates and forecast, 2013 – 2024
5.3.7.2. Market estimates and forecast, by application, 2013 – 2024
5.4 Asia Pacific
5.4.1 Market estimates and forecast, 2013-2024
5.4.2 Market estimates and forecast, by application, 2013-2024
5.4.3 China
5.4.3.1. Market estimates and forecast, 2013 – 2024
5.4.3.2. Market estimates and forecast, by application, 2013 – 2024
5.4.4 Japan
5.4.4.1. Market estimates and forecast, 2013 – 2024
5.4.4.2. Market estimates and forecast, by application, 2013 – 2024
5.5 Latin America (LATAM)
5.5.1 Market estimates and forecast, 2013-2024
5.5.2 Market estimates and forecast, by application, 2013-2024
5.6 Middle East & Africa (MEA)
5.6.1 Market estimates and forecast, 2013-2024
5.6.2 Market estimates and forecast, by application, 2013-2024
Chapter 6 Company Profiles
6.1 Kewpie Corporation
6.1.1 Business Overview
6.1.2 Financial Data
6.1.3 Product Landscape
6.1.4 Strategic Outlook
6.2 Natural Factors
6.2.1 Business Overview
6.2.2 Financial Data
6.2.3 Product Landscape
6.2.4 Strategic Outlook
6.3 Avanti Polar Lipids Inc
6.3.1 Business Overview
6.3.2 Financial Data
6.3.3 Product Landscape
6.3.4 Strategic Outlook
6.4 NOF America Corporation
6.4.1 Business Overview
6.4.2 Financial Data
6.4.3 Product Landscape
6.4.4 Strategic Outlook
6.5 Jena Bioscience GmbH
6.5.1 Business Overview
6.5.2 Financial Data
6.5.3 Product Landscape
6.5.4 Strategic Outlook
6.6 Nutrasal, Inc
6.6.1 Business Overview
6.6.2 Financial Data
6.6.3 Product Landscape
6.6.4 Strategic Outlook
6.7 Lipoid
6.7.1 Business Overview
6.7.2 Financial Data
6.7.3 Product Landscape
6.7.4 Strategic Outlook
